References
- Lekovic D, Miljic P, Mihaljevic B. Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma. Thromb Res 2010;126:477–480.
- Kanemura N, Tsurumi H, Yamada T, et al. Diffuse large B-cell lymphoma with tumor thrombosis in the portal vein. Int J Hematol 2006;84:282–283.
- Mohren M, Markmann I, Jentsch-Ullrich K, et al. Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis. Br J Cancer 2005;92:1349–1351.
- Khorana AA, Francis CW, Culakova E, et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007;110:2339–2346.
- Caruso V, Di Castelnuovo A, Meschengieser S, et al. Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events. Blood 2010;115:5322–5328.
- Negaard H, Dahm A, Sandset PM, et al. Angiogenesis and hemostasis in hematological neoplasias. Curr Drug Targets 2005;6: 683–699.
- Negaard HF, Iversen PO, Ostenstad B, et al. Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor. Thromb Haemost 2008;99:1040–1048.
- Negaard HF, Svennevig K, Kolset SO, et al. Alterations in regulators of the extracellular matrix in non-Hodgkin lymphomas. Leuk Lymphoma 2009;50:998–1004.
- Muslimani AA, Spiro TP, Chaudhry AA, et al. Venous thromboembolism in lymphoma: how effectively are we treating patients? Am J Clin Oncol 2009;32:521–523.